Metraipolis › archive › dc_cb5df138dc82

KRAS G12R in pancreatic cancer: why this mutation resists current inhibitor strategies — Europe PMC PMID:42226005

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42226005
DOI: 10.1093/oncolo/oyag155
License (as archived): solo-consultazione
Archived: 2026-11-01T01:50:58.719Z
SHA-256 of the archived text: d6cfb5669d2949d74b99844a678cd7ba29a613e1fc1f6478e180a6115453a726
Stable URL of this page: https://metraipolis.com/documento/dc_cb5df138dc82

How to cite

KRAS G12R in pancreatic cancer: why this mutation resists current inhibitor strategies — Europe PMC PMID:42226005 — Europe PMC (en), https://europepmc.org/article/MED/42226005 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb5df138dc82 (Metraipolis archive dc_cb5df138dc82, sha256 d6cfb5669d2949d74b99844a678cd7ba29a613e1fc1f6478e180a6115453a726)

BibTeX

@misc{dccb5df138dc82,
  title = {KRAS G12R in pancreatic cancer: why this mutation resists current inhibitor strategies — Europe PMC PMID:42226005},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42226005},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb5df138dc82; sha256 d6cfb5669d2949d74b99844a678cd7ba29a613e1fc1f6478e180a6115453a726},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42226005. Agents can read the archived copy with the MCP tool read_document.